IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS - ANVISA Registration 80000230036
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230036 and manufactured by manufacturer not specified. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Mar 10, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 4 companies making the same product including VENTANA MEDICAL SYSTEM, INC, CELL MARQUE CORPORATION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80000230036
25351551560201683
03290250000100
Company Information
Dates and Status
Dec 26, 2016
10/03/2034
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
Família Marcador de Carcinoma de Linfoma e Leucemia
Not specified
80000230044
Dec 26, 2016
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
Família Marcador de Carcinoma de Linfoma e Leucemia
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.
80000230044
Dec 26, 2016
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA DE MARCADORES DE LINFOMAS E LEUCEMIAS
Not specified
80358430003
Oct 04, 2010
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
Not specified
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Família Marcador de Carcinoma de Linfoma e Leucemia
Not specified
80000230044
Dec 26, 2016